🟢 MDxHealth is trading 7% up in after-hours trading with no clear catalyst identified

MDxHealth is trading at $0.20, up 6.99%, with no clear catalyst identified.

• The search found no new announcement explaining the October 19 after-hours rise.
• The October 15 preliminary Q3 report put revenue at about $22.7 million; full-year guidance of $110–115 million was suspended due to unexpected sales-force turnover.
• BTIG downgraded the stock to Neutral on October 19 after the miss and guidance suspension; that negative context did not clearly explain the gain. Positive broader-market figures may have supported risk sentiment; after-hours volume was unavailable.